Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-03-15 Purchase | 2022-03-15 4:19 pm | Oncocyte Corp | OCX | Levine Mitchell S Chief Financial Officer | 25,000 | $1.166 | $29,150 | 87,080 (Direct) | View |
| 2019-09-12 Purchase(A) | 2020-12-17 5:02 pm | OncoCyte Corp | OCX | Levine Mitchell S CFO | 10,000 | $2.006 | $20,060 | 13,495 (Direct) | View |
| 2020-09-12 Purchase(A) | 2020-12-15 06:02 am | OncoCyte Corp | OCX | Levine Mitchell S CFO | 10,000 | $2.006 | $20,060 | 13,495 (Direct) | View |
| 2020-08-03 Purchase | 2020-08-04 6:47 pm | OncoCyte Corp | OCX | Levine Mitchell S Chief Financial Officer | 10,000 | $1.32 | $13,200 | 36,579 (Direct) | View |
| 2019-09-12 Purchase | 2019-09-12 6:33 pm | OncoCyte Corp | OCX | Levine Mitchell S Chief Financial Officer | 10,000 | $2.006 | $20,060 | 10,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-03-15 Option Award | 2022-03-17 9:21 pm | N/A 2032-03-15 | Oncocyte Corp | OCX | Levine Mitchell S Chief Financial Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2021-04-28 Tax Withholding | 2021-04-30 7:09 pm | N/A N/A | OncoCyte Corp | OCX | Levine Mitchell S Chief Financial Officer | 4,620 | $0 | 62,080 (Direct) | View |
| 2021-04-28 Exercise | 2021-04-30 7:09 pm | N/A N/A | OncoCyte Corp | OCX | Levine Mitchell S Chief Financial Officer | 20,000 | $0 | 62,080 (Direct) | View |
| 2021-02-25 Option Award | 2021-03-01 4:32 pm | N/A 2031-02-24 | OncoCyte Corp | OCX | Levine Mitchell S Chief Financial Officer | 255,000 | $5.34 | 255,000 (Direct) | View |
| 2020-12-11 Option Award | 2020-12-15 06:13 am | N/A N/A | OncoCyte Corp | OCX | Levine Mitchell S CFO | 10,121 | $0 | 46,700 (Direct) | View |
| 2020-04-28 Option Award(A) | 2020-04-30 8:08 pm | N/A N/A | OncoCyte Corp | OCX | Levine Mitchell S Chief Financial Officer | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-04-28 Option Award | 2020-04-30 5:53 pm | N/A N/A | OncoCyte Corp | OCX | Levine Mitchell S Chief Financial Officer | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-03-14 Tax Withholding | 2020-04-20 4:42 pm | N/A N/A | OncoCyte Corp | OCX | Levine Mitchell S Chief Financial Officer | 6,916 | $0 | 26,579 (Direct) | View |
| 2020-03-14 Exercise | 2020-04-20 4:42 pm | N/A N/A | OncoCyte Corp | OCX | Levine Mitchell S Chief Financial Officer | 20,000 | $0 | 26,579 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 9:54 pm | N/A 2030-02-09 | Oncocyte Corp | OCX | Levine Mitchell S Chief Financial Officer | 204,000 | $0 | 204,000 (Direct) | View |